Phosphatidylglycerol (PG)-based liposomes enhance drug delivery by improving stability and biocompatibility, making them ideal for pharmaceutical applications.

Phosphatidylserine (PS)-based liposomes are used for targeted drug delivery and improve the therapeutic index of encapsulated drugs.

DOTAP-based liposomes are cationic liposomes ideal for gene delivery applications, enhancing transfection efficiency.

Cardiolipin-based liposomes are utilized in mitochondrial research and for targeted delivery in cellular therapies.

Diether-based liposomes offer enhanced stability and are suitable for long-term storage and various biomedical applications.

Natural Phosphatidylcholine (PC) lipid extracts liposomes are ideal for enhancing the bioavailability of encapsulated compounds.

Saturated PC lipid extracts-based liposomes provide improved encapsulation efficiency for hydrophilic and hydrophobic drugs.

Natural Phosphatidylserine (PS) lipid extracts-based liposomes support cognitive function and enhance the delivery of neuroprotective agents.

Natural total lipid extracts liposomes provide a balanced lipid profile for versatile drug delivery applications.

Neutral PEGylated liposomes enhance circulation time and reduce immunogenicity for effective drug delivery.

Cationic PEGylated liposomes improve cellular uptake and gene delivery efficiency, making them suitable for genetic therapies.

Anionic PEGylated liposomes offer enhanced stability and reduced clearance rates for targeted drug delivery applications.